Dr. R. Scott Wright and Dr. C Michael Gibson Discuss: Inclisiran Potently And Durably Reduces Ldl-c In A Pooled Analyses Of Phase 3 Studies March 30, 2020 Disclosures: TBA
Dr. William D. Toff and Dr. C. Michael Gibson Discuss: The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial March 29, 2020 Disclosures: TBA
Dr. James V. Freeman and Dr. C. Michael Gibson Discuss: The NCDR Left Atrial Appendage Occlusion (LAAO) Registry: Review Of The First 3 Years March 29, 2020 Disclosures: TBA
Dr. William R. Hiatt and Dr. C. Michael Gibson Discuss: The Benefit And Risk Of Rivaroxaban Plus Aspirin In Patients With Peripheral Artery Disease After Lower Extremity Revascularization (ler) With And Without Concomitant Clopidogrel: A Key Subgroup Analysis From Voyager-pad March 29, 2020 Disclosures: TBA
Dr. Basel Ramlawi and Dr. C. Michael Gibson Discuss: Transcatheter Aortic Valve Replacement In Patients With Severe Bicuspid Aortic Valve Stenosis At Low Predicted Risk Of Mortality March 29, 2020 Disclosures: TBA
Dr. John H. Alexander and Dr. C. Michael Gibson Discuss: How Long To Continue Aspirin After ACS/PCI In Patients With Atrial Fibrillation? Insights From Augustus March 29, 2020 Disclosures: TBA
Dr. George Dangas and Dr. C. Michael Gibson Discuss: Safety And Efficacy Of Ticagrelor Monotherapy After Complex PCI: The TWILIGHT-COMPLEX Substudy March 28, 2020 Disclosures: TBA
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss: Flattening the Coronavirus Curve: Lessons from Singapore March 28, 2020 Disclosures: TBA
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss: The VICTORIA (Vericiguat Global Study In Subjects With Heart Failure With Reduced Ejection Fraction) Trial March 28, 2020 Disclosures: TBA
Dr. Naveen Pereira and Dr. C. Michael Gibson Discuss: Clinical Implementation Of Clopidogrel Pharmacogenetics: The Tailor PCI Trial March 28, 2020 Disclosures: TBA
